FREZENT is a preclinical-stage oncology therapeutics company based in New York. We are developing bispecific antibodies and antibody-drug conjugates aimed at targeting dormant cancer cells that may lead to cancer recurrence. Dormant cancer cells are small residual portions of a tumor that were not completely eliminated by treatment. These cells can remain undetectable in the body for a period of time, but eventually, they can transform back into fast-growing tumors. FREZENT is working on a novel cancer treatment to block the reactivation of dormant cancer cells. To achieve this, we are developing therapeutics that neutralize the metabolic factors supplied by the tumor microenvironment, which support dormant cancer cells. In their dormant state, cancer cells rely on these external supplies, and blocking them will effectively starve the cancer cells and induce cell death. Join us in our mission to ensure a future where long-lasting remission is a reality for all cancer patients.
FREZENT Biological Solutions的外部链接
7 Pennsylvania Plaza
US，NY，New York，10001
January 24, 2:00 – 5:00 PM EST | Great opportunity to meet in person and hear about what we plan to achieve this year. ?? ?? ?? Find the registration link in the comments area. Can't make it in person? virtual link is available as well.
???? Introducing IndieBio NY Class 7, pitching live in NYC on January 24! Come meet the latest founders building the future of planetary and human health.
Great opportunity to connect with our CEO Dr. Natasha Shtraizent and learn about our technology.
I am excited to share that I'll be attending RESI@JPM2024. Looking forward to making meaningful connections and introducing FREZENT Biological Solutions. If you're attending or want to connect virtually, feel free to reach out. ???? #JPMorgan #HealthcareInnovation #RESI2024 #Biotech
As 2023 is coming to an end, we think back and feel overwhelmingly grateful for the support and trust we received from our investors, advisors, friends and, most importantly, our families. Now, we look forward to taking the leap into 2024 and bringing FREZENT Biological Solutions closer to fulfilling our mission, together!